Pharmaceutical laboratories are researching new applications for mRNA vaccine technology — and Moderna is hoping to integrate COVID-19, influenza and respiratory syncytial virus immunization into a single jab.Credit: Adam Glanzman/Bloomberg via Getty
A…
[ad_2]
Source link
